Successful application of PD-1 knockdown CLL-1 CAR-T therapy in two AML patients with post-transplant relapse and failure of anti-CD38 CAR-T cell treatment.
Ma YJ, Dai HP, Cui QY, Cui W, Zhu WJ, Qu CJ, Kang LQ, Zhu MQ, Zhu XM, Liu DD, Feng YF, Shen HJ, Liu TH, Qiu HY, Yu L, Wu DP, Tang XW.
Ma YJ, et al. Among authors: zhu xm, zhu wj, zhu mq.
Am J Cancer Res. 2022 Feb 15;12(2):615-621. eCollection 2022.
Am J Cancer Res. 2022.
PMID: 35261791
Free PMC article.